CGON
Price
$42.58
Change
+$1.21 (+2.92%)
Updated
Dec 3, 04:59 PM (EDT)
Capitalization
3.49B
Intraday BUY SELL Signals
RVMD
Price
$77.73
Change
+$2.42 (+3.21%)
Updated
Dec 3, 04:59 PM (EDT)
Capitalization
14.65B
88 days until earnings call
Intraday BUY SELL Signals
Interact to see
Advertisement

CGON vs RVMD

Header iconCGON vs RVMD Comparison
Open Charts CGON vs RVMDBanner chart's image
CG Oncology
Price$42.58
Change+$1.21 (+2.92%)
Volume$24.22K
Capitalization3.49B
Revolution Medicines
Price$77.73
Change+$2.42 (+3.21%)
Volume$47.06K
Capitalization14.65B
CGON vs RVMD Comparison Chart in %
CGON
Daily Signal:
Gain/Loss:
RVMD
Daily Signal:
Gain/Loss:
View a ticker or compare two or three
VS
CGON vs. RVMD commentary
Dec 04, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is CGON is a Hold and RVMD is a StrongBuy.

Interact to see
Advertisement
COMPARISON
Comparison
Dec 04, 2025
Stock price -- (CGON: $41.37 vs. RVMD: $75.31)
Brand notoriety: CGON and RVMD are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: CGON: 41% vs. RVMD: 27%
Market capitalization -- CGON: $3.49B vs. RVMD: $14.65B
CGON [@Biotechnology] is valued at $3.49B. RVMD’s [@Biotechnology] market capitalization is $14.65B. The market cap for tickers in the [@Biotechnology] industry ranges from $107.98B to $0. The average market capitalization across the [@Biotechnology] industry is $2.19B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

CGON’s FA Score shows that 0 FA rating(s) are green whileRVMD’s FA Score has 0 green FA rating(s).

  • CGON’s FA Score: 0 green, 5 red.
  • RVMD’s FA Score: 0 green, 5 red.
According to our system of comparison, RVMD is a better buy in the long-term than CGON.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

CGON’s TA Score shows that 5 TA indicator(s) are bullish while RVMD’s TA Score has 2 bullish TA indicator(s).

  • CGON’s TA Score: 5 bullish, 4 bearish.
  • RVMD’s TA Score: 2 bullish, 2 bearish.
According to our system of comparison, CGON is a better buy in the short-term than RVMD.

Price Growth

CGON (@Biotechnology) experienced а -9.10% price change this week, while RVMD (@Biotechnology) price change was -1.32% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +0.32%. For the same industry, the average monthly price growth was +1.23%, and the average quarterly price growth was +54.93%.

Reported Earning Dates

RVMD is expected to report earnings on Mar 02, 2026.

Industries' Descriptions

@Biotechnology (+0.32% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
RVMD($14.6B) has a higher market cap than CGON($3.49B). RVMD YTD gains are higher at: 72.176 vs. CGON (44.247). CGON has higher annual earnings (EBITDA): -157.09M vs. RVMD (-883.71M). RVMD has more cash in the bank: 2.14B vs. CGON (661M). CGON has less debt than RVMD: CGON (994K) vs RVMD (133M). CGON has higher revenues than RVMD: CGON (551K) vs RVMD (0).
CGONRVMDCGON / RVMD
Capitalization3.49B14.6B24%
EBITDA-157.09M-883.71M18%
Gain YTD44.24772.17661%
P/E RatioN/AN/A-
Revenue551K0-
Total Cash661M2.14B31%
Total Debt994K133M1%
TECHNICAL ANALYSIS
Technical Analysis
CGONRVMD
RSI
ODDS (%)
N/A
N/A
Stochastic
ODDS (%)
Bearish Trend 6 days ago
88%
N/A
Momentum
ODDS (%)
Bullish Trend 6 days ago
69%
N/A
MACD
ODDS (%)
Bullish Trend 6 days ago
62%
N/A
TrendWeek
ODDS (%)
Bullish Trend 6 days ago
81%
Bullish Trend 6 days ago
80%
TrendMonth
ODDS (%)
Bullish Trend 6 days ago
79%
Bullish Trend 6 days ago
80%
Advances
ODDS (%)
Bullish Trend 9 days ago
77%
Bullish Trend 6 days ago
80%
Declines
ODDS (%)
Bearish Trend 29 days ago
80%
Bearish Trend 14 days ago
76%
BollingerBands
ODDS (%)
Bearish Trend 6 days ago
90%
Bearish Trend 6 days ago
67%
Aroon
ODDS (%)
Bearish Trend 6 days ago
85%
Bullish Trend 6 days ago
79%
View a ticker or compare two or three
Interact to see
Advertisement
CGON
Daily Signal:
Gain/Loss:
RVMD
Daily Signal:
Gain/Loss:
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
ETFs / NAMEPrice $Chg $Chg %
REAI18.800.40
+2.19%
Intelligent Real Estate ETF
MKOR33.260.49
+1.50%
Matthews Korea Active ETF
AIA96.020.40
+0.42%
iShares Asia 50 ETF
JULW38.830.06
+0.16%
AllianzIM US Large Cap Buffer20 Jul ETF
HBMBF240.00N/A
N/A
HBM Bioventures AG

CGON and

Correlation & Price change

A.I.dvisor indicates that over the last year, CGON has been loosely correlated with SYRE. These tickers have moved in lockstep 58% of the time. This A.I.-generated data suggests there is some statistical probability that if CGON jumps, then SYRE could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To CGON
1D Price
Change %
CGON100%
-4.35%
SYRE - CGON
58%
Loosely correlated
-0.91%
ACLX - CGON
57%
Loosely correlated
-2.03%
IDYA - CGON
56%
Loosely correlated
-1.75%
NUVL - CGON
55%
Loosely correlated
-1.37%
XNCR - CGON
54%
Loosely correlated
-3.15%
More

RVMD and

Correlation & Price change

A.I.dvisor indicates that over the last year, RVMD has been loosely correlated with NUVL. These tickers have moved in lockstep 60% of the time. This A.I.-generated data suggests there is some statistical probability that if RVMD jumps, then NUVL could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To RVMD
1D Price
Change %
RVMD100%
-0.65%
NUVL - RVMD
60%
Loosely correlated
-1.37%
CGON - RVMD
53%
Loosely correlated
-4.35%
IRON - RVMD
53%
Loosely correlated
-2.16%
CLDX - RVMD
52%
Loosely correlated
+2.85%
OCUL - RVMD
52%
Loosely correlated
-3.93%
More